The contract research organization uses technology to make clinical trial recruiting, execution and management more efficient.
“[W]e are in a time when we must take a look at how to repair or build the foundation of ophthalmology research with a more efficient, innovative and collaborative approach than ever before,” Ms. Swank said in an Aug. 2 company release. “I’m very excited about the days ahead for Vial Ophthalmology CRO.”
Ms. Swank will be working with Vial’s multidisciplinary scientific advisory board, according to the news release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.